nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxybutynin—CYP3A5—Gefitinib—lung cancer	0.0548	0.087	CbGbCtD
Oxybutynin—CYP3A5—Teniposide—lung cancer	0.0531	0.0844	CbGbCtD
Oxybutynin—CYP2D6—Gefitinib—lung cancer	0.0336	0.0534	CbGbCtD
Oxybutynin—CYP3A5—Crizotinib—lung cancer	0.0336	0.0534	CbGbCtD
Oxybutynin—CYP3A5—Erlotinib—lung cancer	0.0324	0.0515	CbGbCtD
Oxybutynin—CYP2C8—Erlotinib—lung cancer	0.0311	0.0495	CbGbCtD
Oxybutynin—CYP3A5—Paclitaxel—lung cancer	0.0296	0.0471	CbGbCtD
Oxybutynin—CYP3A5—Irinotecan—lung cancer	0.0292	0.0465	CbGbCtD
Oxybutynin—CYP2C8—Paclitaxel—lung cancer	0.0285	0.0453	CbGbCtD
Oxybutynin—CYP2D6—Vinorelbine—lung cancer	0.0259	0.0411	CbGbCtD
Oxybutynin—CYP3A5—Etoposide—lung cancer	0.0234	0.0372	CbGbCtD
Oxybutynin—CYP3A4—Topotecan—lung cancer	0.0234	0.0371	CbGbCtD
Oxybutynin—CYP2C8—Etoposide—lung cancer	0.0225	0.0358	CbGbCtD
Oxybutynin—CYP3A5—Docetaxel—lung cancer	0.0214	0.0341	CbGbCtD
Oxybutynin—CYP3A4—Gefitinib—lung cancer	0.0214	0.0339	CbGbCtD
Oxybutynin—CYP3A4—Teniposide—lung cancer	0.0207	0.0329	CbGbCtD
Oxybutynin—CYP2D6—Erlotinib—lung cancer	0.0199	0.0316	CbGbCtD
Oxybutynin—CYP3A4—Vinorelbine—lung cancer	0.0165	0.0261	CbGbCtD
Oxybutynin—CYP2D6—Vinblastine—lung cancer	0.0159	0.0253	CbGbCtD
Oxybutynin—CYP3A4—Crizotinib—lung cancer	0.0131	0.0208	CbGbCtD
Oxybutynin—CYP3A4—Erlotinib—lung cancer	0.0126	0.0201	CbGbCtD
Oxybutynin—CYP3A4—Paclitaxel—lung cancer	0.0116	0.0184	CbGbCtD
Oxybutynin—CYP3A4—Irinotecan—lung cancer	0.0114	0.0181	CbGbCtD
Oxybutynin—CYP3A4—Vinblastine—lung cancer	0.0101	0.0161	CbGbCtD
Oxybutynin—CYP2D6—Doxorubicin—lung cancer	0.0098	0.0156	CbGbCtD
Oxybutynin—CYP3A4—Etoposide—lung cancer	0.00914	0.0145	CbGbCtD
Oxybutynin—CYP3A4—Docetaxel—lung cancer	0.00836	0.0133	CbGbCtD
Oxybutynin—CYP3A4—Doxorubicin—lung cancer	0.00623	0.0099	CbGbCtD
Oxybutynin—Loss of consciousness—Docetaxel—lung cancer	0.000122	0.000447	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000122	0.000446	CcSEcCtD
Oxybutynin—Somnolence—Etoposide—lung cancer	0.000121	0.000444	CcSEcCtD
Oxybutynin—Cough—Docetaxel—lung cancer	0.000121	0.000443	CcSEcCtD
Oxybutynin—Insomnia—Paclitaxel—lung cancer	0.000121	0.000442	CcSEcCtD
Oxybutynin—Epistaxis—Methotrexate—lung cancer	0.000121	0.000442	CcSEcCtD
Oxybutynin—Hypersensitivity—Irinotecan—lung cancer	0.000121	0.000442	CcSEcCtD
Oxybutynin—Convulsion—Docetaxel—lung cancer	0.00012	0.00044	CcSEcCtD
Oxybutynin—Paraesthesia—Paclitaxel—lung cancer	0.00012	0.000439	CcSEcCtD
Oxybutynin—Hypertension—Docetaxel—lung cancer	0.00012	0.000439	CcSEcCtD
Oxybutynin—Bronchitis—Doxorubicin—lung cancer	0.00012	0.000438	CcSEcCtD
Oxybutynin—Somnolence—Paclitaxel—lung cancer	0.000119	0.000435	CcSEcCtD
Oxybutynin—Decreased appetite—Etoposide—lung cancer	0.000118	0.000434	CcSEcCtD
Oxybutynin—Arthralgia—Docetaxel—lung cancer	0.000118	0.000433	CcSEcCtD
Oxybutynin—Chest pain—Docetaxel—lung cancer	0.000118	0.000433	CcSEcCtD
Oxybutynin—Nausea—Vinorelbine—lung cancer	0.000118	0.000432	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Etoposide—lung cancer	0.000118	0.000431	CcSEcCtD
Oxybutynin—Dyspepsia—Paclitaxel—lung cancer	0.000118	0.000431	CcSEcCtD
Oxybutynin—Asthenia—Irinotecan—lung cancer	0.000118	0.00043	CcSEcCtD
Oxybutynin—Fatigue—Etoposide—lung cancer	0.000118	0.00043	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000117	0.00043	CcSEcCtD
Oxybutynin—Pain—Etoposide—lung cancer	0.000117	0.000427	CcSEcCtD
Oxybutynin—Constipation—Etoposide—lung cancer	0.000117	0.000427	CcSEcCtD
Oxybutynin—Dysuria—Doxorubicin—lung cancer	0.000116	0.000426	CcSEcCtD
Oxybutynin—Decreased appetite—Paclitaxel—lung cancer	0.000116	0.000425	CcSEcCtD
Oxybutynin—Dry mouth—Docetaxel—lung cancer	0.000116	0.000423	CcSEcCtD
Oxybutynin—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000116	0.000423	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000115	0.000422	CcSEcCtD
Oxybutynin—Fatigue—Paclitaxel—lung cancer	0.000115	0.000422	CcSEcCtD
Oxybutynin—Pollakiuria—Doxorubicin—lung cancer	0.000115	0.00042	CcSEcCtD
Oxybutynin—Asthenia—Gemcitabine—lung cancer	0.000115	0.000419	CcSEcCtD
Oxybutynin—Pain—Paclitaxel—lung cancer	0.000114	0.000418	CcSEcCtD
Oxybutynin—Constipation—Paclitaxel—lung cancer	0.000114	0.000418	CcSEcCtD
Oxybutynin—Confusional state—Docetaxel—lung cancer	0.000114	0.000418	CcSEcCtD
Oxybutynin—Pharyngitis—Methotrexate—lung cancer	0.000114	0.000417	CcSEcCtD
Oxybutynin—Urinary tract disorder—Methotrexate—lung cancer	0.000113	0.000415	CcSEcCtD
Oxybutynin—Oedema—Docetaxel—lung cancer	0.000113	0.000415	CcSEcCtD
Oxybutynin—Anaphylactic shock—Docetaxel—lung cancer	0.000113	0.000415	CcSEcCtD
Oxybutynin—Pruritus—Gemcitabine—lung cancer	0.000113	0.000413	CcSEcCtD
Oxybutynin—Urethral disorder—Methotrexate—lung cancer	0.000113	0.000412	CcSEcCtD
Oxybutynin—Infection—Docetaxel—lung cancer	0.000113	0.000412	CcSEcCtD
Oxybutynin—Feeling abnormal—Etoposide—lung cancer	0.000112	0.000411	CcSEcCtD
Oxybutynin—Diarrhoea—Irinotecan—lung cancer	0.000112	0.00041	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Etoposide—lung cancer	0.000111	0.000408	CcSEcCtD
Oxybutynin—Shock—Docetaxel—lung cancer	0.000111	0.000408	CcSEcCtD
Oxybutynin—Nervous system disorder—Docetaxel—lung cancer	0.000111	0.000407	CcSEcCtD
Oxybutynin—Infestation—Doxorubicin—lung cancer	0.000111	0.000406	CcSEcCtD
Oxybutynin—Infestation NOS—Doxorubicin—lung cancer	0.000111	0.000406	CcSEcCtD
Oxybutynin—Drowsiness—Doxorubicin—lung cancer	0.000111	0.000406	CcSEcCtD
Oxybutynin—Visual impairment—Methotrexate—lung cancer	0.000111	0.000405	CcSEcCtD
Oxybutynin—Tachycardia—Docetaxel—lung cancer	0.000111	0.000405	CcSEcCtD
Oxybutynin—Feeling abnormal—Paclitaxel—lung cancer	0.00011	0.000403	CcSEcCtD
Oxybutynin—Skin disorder—Docetaxel—lung cancer	0.00011	0.000403	CcSEcCtD
Oxybutynin—Hypersensitivity—Cisplatin—lung cancer	0.00011	0.000401	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Paclitaxel—lung cancer	0.000109	0.0004	CcSEcCtD
Oxybutynin—Diarrhoea—Gemcitabine—lung cancer	0.000109	0.0004	CcSEcCtD
Oxybutynin—Dizziness—Irinotecan—lung cancer	0.000108	0.000397	CcSEcCtD
Oxybutynin—Urticaria—Etoposide—lung cancer	0.000108	0.000396	CcSEcCtD
Oxybutynin—Stomatitis—Doxorubicin—lung cancer	0.000108	0.000395	CcSEcCtD
Oxybutynin—Anorexia—Docetaxel—lung cancer	0.000108	0.000395	CcSEcCtD
Oxybutynin—Abdominal pain—Etoposide—lung cancer	0.000108	0.000394	CcSEcCtD
Oxybutynin—Conjunctivitis—Doxorubicin—lung cancer	0.000108	0.000394	CcSEcCtD
Oxybutynin—Urinary tract infection—Doxorubicin—lung cancer	0.000108	0.000394	CcSEcCtD
Oxybutynin—Eye disorder—Methotrexate—lung cancer	0.000107	0.000393	CcSEcCtD
Oxybutynin—Tinnitus—Methotrexate—lung cancer	0.000107	0.000392	CcSEcCtD
Oxybutynin—Asthenia—Cisplatin—lung cancer	0.000107	0.000391	CcSEcCtD
Oxybutynin—Cardiac disorder—Methotrexate—lung cancer	0.000107	0.00039	CcSEcCtD
Oxybutynin—Urticaria—Paclitaxel—lung cancer	0.000106	0.000389	CcSEcCtD
Oxybutynin—Hypotension—Docetaxel—lung cancer	0.000106	0.000387	CcSEcCtD
Oxybutynin—Haematuria—Doxorubicin—lung cancer	0.000106	0.000387	CcSEcCtD
Oxybutynin—Abdominal pain—Paclitaxel—lung cancer	0.000106	0.000387	CcSEcCtD
Oxybutynin—Epistaxis—Doxorubicin—lung cancer	0.000105	0.000383	CcSEcCtD
Oxybutynin—Angiopathy—Methotrexate—lung cancer	0.000104	0.000382	CcSEcCtD
Oxybutynin—Vomiting—Irinotecan—lung cancer	0.000104	0.000381	CcSEcCtD
Oxybutynin—Sinusitis—Doxorubicin—lung cancer	0.000104	0.000381	CcSEcCtD
Oxybutynin—Mediastinal disorder—Methotrexate—lung cancer	0.000104	0.000379	CcSEcCtD
Oxybutynin—Rash—Irinotecan—lung cancer	0.000103	0.000378	CcSEcCtD
Oxybutynin—Dermatitis—Irinotecan—lung cancer	0.000103	0.000378	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000103	0.000378	CcSEcCtD
Oxybutynin—Headache—Irinotecan—lung cancer	0.000103	0.000376	CcSEcCtD
Oxybutynin—Insomnia—Docetaxel—lung cancer	0.000102	0.000375	CcSEcCtD
Oxybutynin—Diarrhoea—Cisplatin—lung cancer	0.000102	0.000373	CcSEcCtD
Oxybutynin—Paraesthesia—Docetaxel—lung cancer	0.000102	0.000372	CcSEcCtD
Oxybutynin—Vomiting—Gemcitabine—lung cancer	0.000101	0.000371	CcSEcCtD
Oxybutynin—Somnolence—Docetaxel—lung cancer	0.000101	0.000369	CcSEcCtD
Oxybutynin—Mental disorder—Methotrexate—lung cancer	0.000101	0.000369	CcSEcCtD
Oxybutynin—Rash—Gemcitabine—lung cancer	0.000101	0.000368	CcSEcCtD
Oxybutynin—Dermatitis—Gemcitabine—lung cancer	0.000101	0.000368	CcSEcCtD
Oxybutynin—Hypersensitivity—Etoposide—lung cancer	0.0001	0.000368	CcSEcCtD
Oxybutynin—Malnutrition—Methotrexate—lung cancer	0.0001	0.000366	CcSEcCtD
Oxybutynin—Erythema—Methotrexate—lung cancer	0.0001	0.000366	CcSEcCtD
Oxybutynin—Headache—Gemcitabine—lung cancer	0.0001	0.000366	CcSEcCtD
Oxybutynin—Rhinitis—Doxorubicin—lung cancer	9.98e-05	0.000365	CcSEcCtD
Oxybutynin—Dyspepsia—Docetaxel—lung cancer	9.97e-05	0.000365	CcSEcCtD
Oxybutynin—Hypoaesthesia—Doxorubicin—lung cancer	9.9e-05	0.000362	CcSEcCtD
Oxybutynin—Pharyngitis—Doxorubicin—lung cancer	9.88e-05	0.000362	CcSEcCtD
Oxybutynin—Decreased appetite—Docetaxel—lung cancer	9.85e-05	0.00036	CcSEcCtD
Oxybutynin—Hypersensitivity—Paclitaxel—lung cancer	9.85e-05	0.00036	CcSEcCtD
Oxybutynin—Urinary tract disorder—Doxorubicin—lung cancer	9.83e-05	0.00036	CcSEcCtD
Oxybutynin—Oedema peripheral—Doxorubicin—lung cancer	9.8e-05	0.000359	CcSEcCtD
Oxybutynin—Dysgeusia—Methotrexate—lung cancer	9.8e-05	0.000359	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Docetaxel—lung cancer	9.78e-05	0.000358	CcSEcCtD
Oxybutynin—Asthenia—Etoposide—lung cancer	9.78e-05	0.000358	CcSEcCtD
Oxybutynin—Connective tissue disorder—Doxorubicin—lung cancer	9.78e-05	0.000358	CcSEcCtD
Oxybutynin—Fatigue—Docetaxel—lung cancer	9.77e-05	0.000357	CcSEcCtD
Oxybutynin—Urethral disorder—Doxorubicin—lung cancer	9.75e-05	0.000357	CcSEcCtD
Oxybutynin—Nausea—Irinotecan—lung cancer	9.73e-05	0.000356	CcSEcCtD
Oxybutynin—Pain—Docetaxel—lung cancer	9.69e-05	0.000355	CcSEcCtD
Oxybutynin—Constipation—Docetaxel—lung cancer	9.69e-05	0.000355	CcSEcCtD
Oxybutynin—Back pain—Methotrexate—lung cancer	9.68e-05	0.000354	CcSEcCtD
Oxybutynin—Pruritus—Etoposide—lung cancer	9.64e-05	0.000353	CcSEcCtD
Oxybutynin—Visual impairment—Doxorubicin—lung cancer	9.59e-05	0.000351	CcSEcCtD
Oxybutynin—Asthenia—Paclitaxel—lung cancer	9.59e-05	0.000351	CcSEcCtD
Oxybutynin—Nausea—Gemcitabine—lung cancer	9.48e-05	0.000347	CcSEcCtD
Oxybutynin—Vomiting—Cisplatin—lung cancer	9.46e-05	0.000346	CcSEcCtD
Oxybutynin—Pruritus—Paclitaxel—lung cancer	9.46e-05	0.000346	CcSEcCtD
Oxybutynin—Vision blurred—Methotrexate—lung cancer	9.43e-05	0.000345	CcSEcCtD
Oxybutynin—Rash—Cisplatin—lung cancer	9.38e-05	0.000343	CcSEcCtD
Oxybutynin—Dermatitis—Cisplatin—lung cancer	9.37e-05	0.000343	CcSEcCtD
Oxybutynin—Feeling abnormal—Docetaxel—lung cancer	9.34e-05	0.000342	CcSEcCtD
Oxybutynin—Diarrhoea—Etoposide—lung cancer	9.33e-05	0.000341	CcSEcCtD
Oxybutynin—Eye disorder—Doxorubicin—lung cancer	9.3e-05	0.00034	CcSEcCtD
Oxybutynin—Ill-defined disorder—Methotrexate—lung cancer	9.28e-05	0.00034	CcSEcCtD
Oxybutynin—Tinnitus—Doxorubicin—lung cancer	9.28e-05	0.00034	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Docetaxel—lung cancer	9.26e-05	0.000339	CcSEcCtD
Oxybutynin—Flushing—Doxorubicin—lung cancer	9.24e-05	0.000338	CcSEcCtD
Oxybutynin—Cardiac disorder—Doxorubicin—lung cancer	9.24e-05	0.000338	CcSEcCtD
Oxybutynin—Diarrhoea—Paclitaxel—lung cancer	9.14e-05	0.000335	CcSEcCtD
Oxybutynin—Angiopathy—Doxorubicin—lung cancer	9.03e-05	0.00033	CcSEcCtD
Oxybutynin—Malaise—Methotrexate—lung cancer	9.02e-05	0.00033	CcSEcCtD
Oxybutynin—Dizziness—Etoposide—lung cancer	9.01e-05	0.00033	CcSEcCtD
Oxybutynin—Mediastinal disorder—Doxorubicin—lung cancer	8.97e-05	0.000328	CcSEcCtD
Oxybutynin—Abdominal pain—Docetaxel—lung cancer	8.96e-05	0.000328	CcSEcCtD
Oxybutynin—Arrhythmia—Doxorubicin—lung cancer	8.89e-05	0.000325	CcSEcCtD
Oxybutynin—Dizziness—Paclitaxel—lung cancer	8.84e-05	0.000323	CcSEcCtD
Oxybutynin—Nausea—Cisplatin—lung cancer	8.84e-05	0.000323	CcSEcCtD
Oxybutynin—Cough—Methotrexate—lung cancer	8.73e-05	0.00032	CcSEcCtD
Oxybutynin—Mental disorder—Doxorubicin—lung cancer	8.72e-05	0.000319	CcSEcCtD
Oxybutynin—Convulsion—Methotrexate—lung cancer	8.67e-05	0.000317	CcSEcCtD
Oxybutynin—Vomiting—Etoposide—lung cancer	8.67e-05	0.000317	CcSEcCtD
Oxybutynin—Erythema—Doxorubicin—lung cancer	8.66e-05	0.000317	CcSEcCtD
Oxybutynin—Malnutrition—Doxorubicin—lung cancer	8.66e-05	0.000317	CcSEcCtD
Oxybutynin—Rash—Etoposide—lung cancer	8.59e-05	0.000315	CcSEcCtD
Oxybutynin—Dermatitis—Etoposide—lung cancer	8.59e-05	0.000314	CcSEcCtD
Oxybutynin—Headache—Etoposide—lung cancer	8.54e-05	0.000313	CcSEcCtD
Oxybutynin—Flatulence—Doxorubicin—lung cancer	8.54e-05	0.000312	CcSEcCtD
Oxybutynin—Arthralgia—Methotrexate—lung cancer	8.52e-05	0.000312	CcSEcCtD
Oxybutynin—Chest pain—Methotrexate—lung cancer	8.52e-05	0.000312	CcSEcCtD
Oxybutynin—Tension—Doxorubicin—lung cancer	8.5e-05	0.000311	CcSEcCtD
Oxybutynin—Vomiting—Paclitaxel—lung cancer	8.5e-05	0.000311	CcSEcCtD
Oxybutynin—Dysgeusia—Doxorubicin—lung cancer	8.48e-05	0.00031	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	8.46e-05	0.00031	CcSEcCtD
Oxybutynin—Rash—Paclitaxel—lung cancer	8.43e-05	0.000308	CcSEcCtD
Oxybutynin—Dermatitis—Paclitaxel—lung cancer	8.42e-05	0.000308	CcSEcCtD
Oxybutynin—Discomfort—Methotrexate—lung cancer	8.42e-05	0.000308	CcSEcCtD
Oxybutynin—Nervousness—Doxorubicin—lung cancer	8.41e-05	0.000308	CcSEcCtD
Oxybutynin—Back pain—Doxorubicin—lung cancer	8.38e-05	0.000307	CcSEcCtD
Oxybutynin—Headache—Paclitaxel—lung cancer	8.37e-05	0.000306	CcSEcCtD
Oxybutynin—Hypersensitivity—Docetaxel—lung cancer	8.35e-05	0.000305	CcSEcCtD
Oxybutynin—Confusional state—Methotrexate—lung cancer	8.23e-05	0.000301	CcSEcCtD
Oxybutynin—Anaphylactic shock—Methotrexate—lung cancer	8.16e-05	0.000299	CcSEcCtD
Oxybutynin—Vision blurred—Doxorubicin—lung cancer	8.16e-05	0.000299	CcSEcCtD
Oxybutynin—Asthenia—Docetaxel—lung cancer	8.13e-05	0.000297	CcSEcCtD
Oxybutynin—Infection—Methotrexate—lung cancer	8.11e-05	0.000297	CcSEcCtD
Oxybutynin—Nausea—Etoposide—lung cancer	8.1e-05	0.000296	CcSEcCtD
Oxybutynin—Ill-defined disorder—Doxorubicin—lung cancer	8.04e-05	0.000294	CcSEcCtD
Oxybutynin—Pruritus—Docetaxel—lung cancer	8.01e-05	0.000293	CcSEcCtD
Oxybutynin—Nervous system disorder—Methotrexate—lung cancer	8.01e-05	0.000293	CcSEcCtD
Oxybutynin—Agitation—Doxorubicin—lung cancer	7.96e-05	0.000291	CcSEcCtD
Oxybutynin—Nausea—Paclitaxel—lung cancer	7.94e-05	0.000291	CcSEcCtD
Oxybutynin—Skin disorder—Methotrexate—lung cancer	7.93e-05	0.00029	CcSEcCtD
Oxybutynin—Malaise—Doxorubicin—lung cancer	7.81e-05	0.000286	CcSEcCtD
Oxybutynin—Anorexia—Methotrexate—lung cancer	7.78e-05	0.000285	CcSEcCtD
Oxybutynin—Syncope—Doxorubicin—lung cancer	7.77e-05	0.000284	CcSEcCtD
Oxybutynin—Diarrhoea—Docetaxel—lung cancer	7.75e-05	0.000284	CcSEcCtD
Oxybutynin—Palpitations—Doxorubicin—lung cancer	7.66e-05	0.00028	CcSEcCtD
Oxybutynin—Hypotension—Methotrexate—lung cancer	7.63e-05	0.000279	CcSEcCtD
Oxybutynin—Loss of consciousness—Doxorubicin—lung cancer	7.61e-05	0.000279	CcSEcCtD
Oxybutynin—Cough—Doxorubicin—lung cancer	7.56e-05	0.000277	CcSEcCtD
Oxybutynin—Convulsion—Doxorubicin—lung cancer	7.51e-05	0.000275	CcSEcCtD
Oxybutynin—Dizziness—Docetaxel—lung cancer	7.49e-05	0.000274	CcSEcCtD
Oxybutynin—Hypertension—Doxorubicin—lung cancer	7.48e-05	0.000274	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Methotrexate—lung cancer	7.44e-05	0.000272	CcSEcCtD
Oxybutynin—Insomnia—Methotrexate—lung cancer	7.38e-05	0.00027	CcSEcCtD
Oxybutynin—Arthralgia—Doxorubicin—lung cancer	7.37e-05	0.00027	CcSEcCtD
Oxybutynin—Chest pain—Doxorubicin—lung cancer	7.37e-05	0.00027	CcSEcCtD
Oxybutynin—Anxiety—Doxorubicin—lung cancer	7.35e-05	0.000269	CcSEcCtD
Oxybutynin—Paraesthesia—Methotrexate—lung cancer	7.33e-05	0.000268	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	7.32e-05	0.000268	CcSEcCtD
Oxybutynin—Discomfort—Doxorubicin—lung cancer	7.29e-05	0.000267	CcSEcCtD
Oxybutynin—Somnolence—Methotrexate—lung cancer	7.26e-05	0.000266	CcSEcCtD
Oxybutynin—Dry mouth—Doxorubicin—lung cancer	7.21e-05	0.000264	CcSEcCtD
Oxybutynin—Vomiting—Docetaxel—lung cancer	7.2e-05	0.000264	CcSEcCtD
Oxybutynin—Dyspepsia—Methotrexate—lung cancer	7.19e-05	0.000263	CcSEcCtD
Oxybutynin—Rash—Docetaxel—lung cancer	7.14e-05	0.000261	CcSEcCtD
Oxybutynin—Dermatitis—Docetaxel—lung cancer	7.14e-05	0.000261	CcSEcCtD
Oxybutynin—Confusional state—Doxorubicin—lung cancer	7.13e-05	0.000261	CcSEcCtD
Oxybutynin—Decreased appetite—Methotrexate—lung cancer	7.1e-05	0.00026	CcSEcCtD
Oxybutynin—Headache—Docetaxel—lung cancer	7.1e-05	0.00026	CcSEcCtD
Oxybutynin—Oedema—Doxorubicin—lung cancer	7.07e-05	0.000259	CcSEcCtD
Oxybutynin—Anaphylactic shock—Doxorubicin—lung cancer	7.07e-05	0.000259	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Methotrexate—lung cancer	7.05e-05	0.000258	CcSEcCtD
Oxybutynin—Fatigue—Methotrexate—lung cancer	7.04e-05	0.000258	CcSEcCtD
Oxybutynin—Infection—Doxorubicin—lung cancer	7.02e-05	0.000257	CcSEcCtD
Oxybutynin—Pain—Methotrexate—lung cancer	6.98e-05	0.000256	CcSEcCtD
Oxybutynin—Shock—Doxorubicin—lung cancer	6.96e-05	0.000255	CcSEcCtD
Oxybutynin—Nervous system disorder—Doxorubicin—lung cancer	6.93e-05	0.000254	CcSEcCtD
Oxybutynin—Tachycardia—Doxorubicin—lung cancer	6.9e-05	0.000253	CcSEcCtD
Oxybutynin—Skin disorder—Doxorubicin—lung cancer	6.87e-05	0.000251	CcSEcCtD
Oxybutynin—Anorexia—Doxorubicin—lung cancer	6.74e-05	0.000247	CcSEcCtD
Oxybutynin—Nausea—Docetaxel—lung cancer	6.73e-05	0.000246	CcSEcCtD
Oxybutynin—Feeling abnormal—Methotrexate—lung cancer	6.73e-05	0.000246	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Methotrexate—lung cancer	6.68e-05	0.000244	CcSEcCtD
Oxybutynin—Hypotension—Doxorubicin—lung cancer	6.61e-05	0.000242	CcSEcCtD
Oxybutynin—Urticaria—Methotrexate—lung cancer	6.49e-05	0.000237	CcSEcCtD
Oxybutynin—Abdominal pain—Methotrexate—lung cancer	6.45e-05	0.000236	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Doxorubicin—lung cancer	6.44e-05	0.000236	CcSEcCtD
Oxybutynin—Insomnia—Doxorubicin—lung cancer	6.39e-05	0.000234	CcSEcCtD
Oxybutynin—Paraesthesia—Doxorubicin—lung cancer	6.35e-05	0.000232	CcSEcCtD
Oxybutynin—Somnolence—Doxorubicin—lung cancer	6.29e-05	0.00023	CcSEcCtD
Oxybutynin—Dyspepsia—Doxorubicin—lung cancer	6.22e-05	0.000228	CcSEcCtD
Oxybutynin—Decreased appetite—Doxorubicin—lung cancer	6.15e-05	0.000225	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Doxorubicin—lung cancer	6.1e-05	0.000223	CcSEcCtD
Oxybutynin—Fatigue—Doxorubicin—lung cancer	6.1e-05	0.000223	CcSEcCtD
Oxybutynin—Pain—Doxorubicin—lung cancer	6.05e-05	0.000221	CcSEcCtD
Oxybutynin—Constipation—Doxorubicin—lung cancer	6.05e-05	0.000221	CcSEcCtD
Oxybutynin—Hypersensitivity—Methotrexate—lung cancer	6.02e-05	0.00022	CcSEcCtD
Oxybutynin—Asthenia—Methotrexate—lung cancer	5.86e-05	0.000214	CcSEcCtD
Oxybutynin—Feeling abnormal—Doxorubicin—lung cancer	5.83e-05	0.000213	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Doxorubicin—lung cancer	5.78e-05	0.000212	CcSEcCtD
Oxybutynin—Pruritus—Methotrexate—lung cancer	5.78e-05	0.000211	CcSEcCtD
Oxybutynin—Urticaria—Doxorubicin—lung cancer	5.62e-05	0.000206	CcSEcCtD
Oxybutynin—Abdominal pain—Doxorubicin—lung cancer	5.59e-05	0.000205	CcSEcCtD
Oxybutynin—Diarrhoea—Methotrexate—lung cancer	5.59e-05	0.000204	CcSEcCtD
Oxybutynin—Dizziness—Methotrexate—lung cancer	5.4e-05	0.000198	CcSEcCtD
Oxybutynin—Hypersensitivity—Doxorubicin—lung cancer	5.21e-05	0.000191	CcSEcCtD
Oxybutynin—Vomiting—Methotrexate—lung cancer	5.19e-05	0.00019	CcSEcCtD
Oxybutynin—Rash—Methotrexate—lung cancer	5.15e-05	0.000188	CcSEcCtD
Oxybutynin—Dermatitis—Methotrexate—lung cancer	5.14e-05	0.000188	CcSEcCtD
Oxybutynin—Headache—Methotrexate—lung cancer	5.11e-05	0.000187	CcSEcCtD
Oxybutynin—Asthenia—Doxorubicin—lung cancer	5.07e-05	0.000186	CcSEcCtD
Oxybutynin—Pruritus—Doxorubicin—lung cancer	5e-05	0.000183	CcSEcCtD
Oxybutynin—Nausea—Methotrexate—lung cancer	4.85e-05	0.000178	CcSEcCtD
Oxybutynin—Diarrhoea—Doxorubicin—lung cancer	4.84e-05	0.000177	CcSEcCtD
Oxybutynin—Dizziness—Doxorubicin—lung cancer	4.68e-05	0.000171	CcSEcCtD
Oxybutynin—Vomiting—Doxorubicin—lung cancer	4.5e-05	0.000165	CcSEcCtD
Oxybutynin—Rash—Doxorubicin—lung cancer	4.46e-05	0.000163	CcSEcCtD
Oxybutynin—Dermatitis—Doxorubicin—lung cancer	4.45e-05	0.000163	CcSEcCtD
Oxybutynin—Headache—Doxorubicin—lung cancer	4.43e-05	0.000162	CcSEcCtD
Oxybutynin—Nausea—Doxorubicin—lung cancer	4.2e-05	0.000154	CcSEcCtD
Oxybutynin—CYP3A4—Metabolism—NCOA3—lung cancer	9.25e-06	9.49e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—PIK3CD—lung cancer	9.1e-06	9.34e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—CXCL8—lung cancer	9.08e-06	9.32e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—GSTP1—lung cancer	9.07e-06	9.31e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—HRAS—lung cancer	9.02e-06	9.26e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ADCY1—lung cancer	9e-06	9.23e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ABCG2—lung cancer	9e-06	9.23e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—ALB—lung cancer	8.99e-06	9.22e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—CAT—lung cancer	8.83e-06	9.05e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ENO2—lung cancer	8.82e-06	9.05e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—HPGDS—lung cancer	8.82e-06	9.05e-05	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR downstream signaling—AKT1—lung cancer	8.77e-06	9e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PPP2R1B—lung cancer	8.77e-06	8.99e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PIK3CG—lung cancer	8.71e-06	8.93e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—CASP3—lung cancer	8.69e-06	8.92e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—KIT—lung cancer	8.69e-06	8.91e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—PIK3CG—lung cancer	8.69e-06	8.91e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—APC—lung cancer	8.69e-06	8.91e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—NRAS—lung cancer	8.68e-06	8.91e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—IL2—lung cancer	8.68e-06	8.9e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—APC—lung cancer	8.66e-06	8.88e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—PIK3CG—lung cancer	8.66e-06	8.88e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—KIT—lung cancer	8.66e-06	8.88e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—NRAS—lung cancer	8.66e-06	8.88e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—IL6—lung cancer	8.64e-06	8.86e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—ABCB1—lung cancer	8.59e-06	8.81e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—EGF—lung cancer	8.58e-06	8.81e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—PIK3CG—lung cancer	8.57e-06	8.79e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—APC—lung cancer	8.57e-06	8.79e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—KIT—lung cancer	8.57e-06	8.79e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—NRAS—lung cancer	8.57e-06	8.79e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—GSTT1—lung cancer	8.56e-06	8.78e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—EGF—lung cancer	8.56e-06	8.78e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—EGF—lung cancer	8.47e-06	8.69e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—CCND1—lung cancer	8.46e-06	8.68e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—GCLC—lung cancer	8.46e-06	8.68e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CYP2A6—lung cancer	8.46e-06	8.68e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—JUN—lung cancer	8.44e-06	8.66e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—TYMS—lung cancer	8.43e-06	8.65e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—GSTM1—lung cancer	8.34e-06	8.55e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—MAPK3—lung cancer	8.32e-06	8.53e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—MAPK3—lung cancer	8.29e-06	8.5e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—POMC—lung cancer	8.29e-06	8.5e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—POMC—lung cancer	8.27e-06	8.48e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—APOA1—lung cancer	8.26e-06	8.47e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—POMC—lung cancer	8.24e-06	8.45e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—MMP9—lung cancer	8.22e-06	8.43e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—MAPK3—lung cancer	8.21e-06	8.42e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—CDKN1A—lung cancer	8.19e-06	8.4e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—PTEN—lung cancer	8.17e-06	8.38e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—BRAF—lung cancer	8.16e-06	8.37e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—POMC—lung cancer	8.16e-06	8.37e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—BRAF—lung cancer	8.14e-06	8.35e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—CREBBP—lung cancer	8.07e-06	8.28e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—IL6R—lung cancer	8.06e-06	8.27e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—BRAF—lung cancer	8.06e-06	8.27e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CREBBP—lung cancer	8.05e-06	8.26e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—IL6R—lung cancer	8.04e-06	8.25e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CREBBP—lung cancer	8.03e-06	8.23e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ENO1—lung cancer	8.02e-06	8.22e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—AKT1—lung cancer	7.97e-06	8.17e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—IL6R—lung cancer	7.96e-06	8.17e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CREBBP—lung cancer	7.95e-06	8.15e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—PIK3CB—lung cancer	7.93e-06	8.14e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—EGFR—lung cancer	7.91e-06	8.12e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	7.91e-06	8.11e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—CYP1A1—lung cancer	7.9e-06	8.11e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—EGFR—lung cancer	7.89e-06	8.09e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—PTGS2—lung cancer	7.86e-06	8.06e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—ERCC2—lung cancer	7.84e-06	8.04e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—EGFR—lung cancer	7.81e-06	8.01e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—EP300—lung cancer	7.79e-06	7.99e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—MAP2K1—lung cancer	7.69e-06	7.88e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—MAP2K1—lung cancer	7.66e-06	7.86e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PIK3CD—lung cancer	7.65e-06	7.85e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—PIK3CD—lung cancer	7.64e-06	7.83e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—PIK3CD—lung cancer	7.61e-06	7.81e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—MAP2K1—lung cancer	7.59e-06	7.78e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—SRC—lung cancer	7.57e-06	7.77e-05	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—PIK3CA—lung cancer	7.56e-06	7.76e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—ALB—lung cancer	7.56e-06	7.75e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PIK3CG—lung cancer	7.54e-06	7.73e-05	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—PIK3CA—lung cancer	7.54e-06	7.73e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—PIK3CD—lung cancer	7.54e-06	7.73e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—KRAS—lung cancer	7.48e-06	7.67e-05	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—PIK3CA—lung cancer	7.47e-06	7.66e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—KRAS—lung cancer	7.45e-06	7.64e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—KRAS—lung cancer	7.38e-06	7.57e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—VEGFA—lung cancer	7.38e-06	7.57e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—STAT3—lung cancer	7.3e-06	7.49e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—NRAS—lung cancer	7.29e-06	7.47e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CYP2E1—lung cancer	7.19e-06	7.38e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—POMC—lung cancer	7.18e-06	7.36e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—NQO1—lung cancer	7.11e-06	7.29e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—CREBBP—lung cancer	6.99e-06	7.17e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—MAPK3—lung cancer	6.98e-06	7.16e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—PIK3CA—lung cancer	6.87e-06	7.04e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—PTEN—lung cancer	6.86e-06	7.03e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—PIK3CA—lung cancer	6.85e-06	7.02e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—MDM2—lung cancer	6.84e-06	7.02e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—MDM2—lung cancer	6.82e-06	6.99e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—RAF1—lung cancer	6.82e-06	6.99e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—RAF1—lung cancer	6.79e-06	6.97e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—MYC—lung cancer	6.79e-06	6.96e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—APOA1—lung cancer	6.78e-06	6.95e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—PIK3CA—lung cancer	6.78e-06	6.95e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—MDM2—lung cancer	6.75e-06	6.93e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—ERBB2—lung cancer	6.74e-06	6.92e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—RAF1—lung cancer	6.73e-06	6.9e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—ERBB2—lung cancer	6.72e-06	6.89e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PIK3CB—lung cancer	6.67e-06	6.84e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—ERBB2—lung cancer	6.66e-06	6.83e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—MTOR—lung cancer	6.65e-06	6.83e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—PIK3CB—lung cancer	6.65e-06	6.83e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—EGFR—lung cancer	6.64e-06	6.81e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—PIK3CB—lung cancer	6.63e-06	6.8e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—MTOR—lung cancer	6.63e-06	6.8e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PIK3CD—lung cancer	6.63e-06	6.8e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PTGS2—lung cancer	6.61e-06	6.78e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—MTOR—lung cancer	6.57e-06	6.74e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—PIK3CB—lung cancer	6.57e-06	6.74e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—ALB—lung cancer	6.54e-06	6.71e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—EP300—lung cancer	6.54e-06	6.71e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—STK11—lung cancer	6.41e-06	6.58e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CXCL8—lung cancer	6.4e-06	6.56e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CXCL8—lung cancer	6.37e-06	6.54e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—HRAS—lung cancer	6.35e-06	6.52e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—HRAS—lung cancer	6.33e-06	6.5e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CXCL8—lung cancer	6.31e-06	6.47e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—HRAS—lung cancer	6.27e-06	6.43e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—KRAS—lung cancer	6.27e-06	6.43e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PIK3CG—lung cancer	6.19e-06	6.35e-05	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—AKT1—lung cancer	6.18e-06	6.34e-05	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—AKT1—lung cancer	6.16e-06	6.32e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CASP3—lung cancer	6.12e-06	6.28e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—IL2—lung cancer	6.11e-06	6.27e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CASP3—lung cancer	6.1e-06	6.26e-05	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—AKT1—lung cancer	6.1e-06	6.25e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—IL2—lung cancer	6.09e-06	6.25e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—IL6—lung cancer	6.08e-06	6.24e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—IL6—lung cancer	6.06e-06	6.22e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CASP3—lung cancer	6.04e-06	6.2e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—IL2—lung cancer	6.03e-06	6.19e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—IL6—lung cancer	6e-06	6.16e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CCND1—lung cancer	5.96e-06	6.11e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—JUN—lung cancer	5.95e-06	6.1e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CCND1—lung cancer	5.94e-06	6.09e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—GSTP1—lung cancer	5.93e-06	6.08e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—JUN—lung cancer	5.93e-06	6.08e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—POMC—lung cancer	5.89e-06	6.04e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CCND1—lung cancer	5.88e-06	6.03e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—JUN—lung cancer	5.87e-06	6.02e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—MMP9—lung cancer	5.78e-06	5.93e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PIK3CB—lung cancer	5.78e-06	5.93e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CAT—lung cancer	5.77e-06	5.92e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—MMP9—lung cancer	5.77e-06	5.91e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PTEN—lung cancer	5.76e-06	5.91e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CDKN1A—lung cancer	5.76e-06	5.91e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—PIK3CA—lung cancer	5.76e-06	5.91e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—PTEN—lung cancer	5.75e-06	5.9e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CDKN1A—lung cancer	5.75e-06	5.89e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—CREBBP—lung cancer	5.74e-06	5.89e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—PTEN—lung cancer	5.73e-06	5.88e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PTGS2—lung cancer	5.73e-06	5.87e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—MMP9—lung cancer	5.71e-06	5.86e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CDKN1A—lung cancer	5.69e-06	5.84e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—PTEN—lung cancer	5.68e-06	5.82e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ABCB1—lung cancer	5.61e-06	5.76e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—AKT1—lung cancer	5.61e-06	5.75e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—AKT1—lung cancer	5.59e-06	5.74e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—TP53—lung cancer	5.57e-06	5.72e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—AKT1—lung cancer	5.54e-06	5.68e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—TYMS—lung cancer	5.51e-06	5.66e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—EP300—lung cancer	5.5e-06	5.64e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—EP300—lung cancer	5.48e-06	5.62e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—EP300—lung cancer	5.47e-06	5.61e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—GSTM1—lung cancer	5.45e-06	5.59e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PIK3CD—lung cancer	5.44e-06	5.58e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—EP300—lung cancer	5.41e-06	5.55e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—ALB—lung cancer	5.37e-06	5.51e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—SRC—lung cancer	5.33e-06	5.47e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—HRAS—lung cancer	5.33e-06	5.47e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—SRC—lung cancer	5.32e-06	5.45e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—SRC—lung cancer	5.26e-06	5.4e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—VEGFA—lung cancer	5.19e-06	5.33e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—VEGFA—lung cancer	5.18e-06	5.31e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CYP1A1—lung cancer	5.17e-06	5.3e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—STAT3—lung cancer	5.14e-06	5.27e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—NRAS—lung cancer	5.13e-06	5.26e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—VEGFA—lung cancer	5.13e-06	5.26e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—STAT3—lung cancer	5.13e-06	5.26e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ERCC2—lung cancer	5.13e-06	5.26e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—NRAS—lung cancer	5.11e-06	5.25e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—IL6—lung cancer	5.1e-06	5.23e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—STAT3—lung cancer	5.08e-06	5.21e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—NRAS—lung cancer	5.06e-06	5.19e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PTEN—lung cancer	4.99e-06	5.12e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—MAPK3—lung cancer	4.91e-06	5.04e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—MAPK3—lung cancer	4.9e-06	5.02e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—MAPK3—lung cancer	4.85e-06	4.97e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—PIK3CA—lung cancer	4.84e-06	4.96e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—MYC—lung cancer	4.78e-06	4.9e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—MYC—lung cancer	4.76e-06	4.89e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—EP300—lung cancer	4.76e-06	4.88e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PIK3CB—lung cancer	4.74e-06	4.87e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—MYC—lung cancer	4.72e-06	4.84e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—AKT1—lung cancer	4.71e-06	4.83e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PTGS2—lung cancer	4.7e-06	4.82e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—EGFR—lung cancer	4.67e-06	4.79e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—EGFR—lung cancer	4.66e-06	4.78e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—EGFR—lung cancer	4.61e-06	4.73e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—APOA1—lung cancer	4.43e-06	4.55e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—KRAS—lung cancer	4.42e-06	4.53e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—KRAS—lung cancer	4.4e-06	4.51e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—KRAS—lung cancer	4.36e-06	4.47e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PTEN—lung cancer	4.1e-06	4.2e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PIK3CA—lung cancer	4.07e-06	4.17e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—PIK3CA—lung cancer	4.06e-06	4.16e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PIK3CG—lung cancer	4.05e-06	4.15e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—PIK3CA—lung cancer	4.04e-06	4.15e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—PIK3CA—lung cancer	4e-06	4.11e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—AKT1—lung cancer	3.95e-06	4.05e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—TP53—lung cancer	3.92e-06	4.03e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—TP53—lung cancer	3.91e-06	4.01e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—EP300—lung cancer	3.91e-06	4.01e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—TP53—lung cancer	3.87e-06	3.97e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—POMC—lung cancer	3.85e-06	3.95e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—HRAS—lung cancer	3.75e-06	3.85e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CREBBP—lung cancer	3.75e-06	3.85e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—HRAS—lung cancer	3.74e-06	3.84e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—HRAS—lung cancer	3.71e-06	3.8e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—IL6—lung cancer	3.59e-06	3.68e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—IL6—lung cancer	3.58e-06	3.67e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PIK3CD—lung cancer	3.56e-06	3.65e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—IL6—lung cancer	3.55e-06	3.64e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PIK3CA—lung cancer	3.52e-06	3.61e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ALB—lung cancer	3.51e-06	3.6e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—AKT1—lung cancer	3.32e-06	3.41e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—AKT1—lung cancer	3.31e-06	3.4e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—AKT1—lung cancer	3.3e-06	3.39e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—AKT1—lung cancer	3.27e-06	3.36e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PIK3CB—lung cancer	3.1e-06	3.18e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PTGS2—lung cancer	3.07e-06	3.15e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PIK3CA—lung cancer	2.89e-06	2.97e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—AKT1—lung cancer	2.88e-06	2.95e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PTEN—lung cancer	2.68e-06	2.75e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—EP300—lung cancer	2.56e-06	2.62e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—AKT1—lung cancer	2.36e-06	2.42e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PIK3CA—lung cancer	1.89e-06	1.94e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—AKT1—lung cancer	1.54e-06	1.58e-05	CbGpPWpGaD
